Search results for “Hyperlipidemia” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 13,404 patents, we discovered top 480 key players by total patent application. Eli Lilly & Co., Merck & Co., Inc., Merck Sharp & Dohme Corp. are dominant in this area. They take 8.29% of the total patent filing.
Indiana, United States
Patent: 487
New Jersey, United States
Patent: 314
New Jersey, United States
Patent: 310
New Jersey, United States
Patent: 298
Basel-Stadt, Switzerland
Patent: 253
United States
Patent: 238
Jiangsu Sheng, China
Patent: 236
Connecticut, United States
Patent: 222
Antwerpen, Belgium
Patent: 190
Switzerland
Patent: 172
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 64 patents, we discovered top 11 start-ups by total patent application. ImmunoMet Therapeutics, Inc., NewAmsterdam Pharma Holding BV, Institut National de la Santé et de la Recherche Médicale are active in this area.
STARTUP
Texas, United States
Patent: 22
STARTUP
Noord-Holland, Netherlands
Patent: 14
STARTUP
France
Patent: 11
STARTUP
Kanagawa-ken, Japan
Patent: 6
STARTUP
ARKAY Therapeutics, LLC
New Jersey, United States
Patent: 4
STARTUP
South Korea
Patent: 2
STARTUP
Shanghai Shi, China
Patent: 1
STARTUP
Hokkaido, Japan
Patent: 1
STARTUP
Buckinghamshire, United Kingdom
Patent: 1
STARTUP
Synaps SAS
France
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1,853 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Alnylam Pharmaceuticals, Inc., China Pharmaceutical University, Chinese Academy of Medical Scciences & Peking Union Medical College take 3.99% of patent filing during this period.
Massachusetts, United States
Patent: 41
Jiangsu Sheng, China
Patent: 19
New York, United States
Patent: 14
Maharashtra, India
Patent: 14
South Korea
Patent: 12
undefined undefined
Patent: 10
Hubei Sheng, China
Patent: 9
South Korea
Patent: 9
California, United States
Patent: 8
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1,853 patents in last 5 years, we discover 372 new entrants. Sun Pharmaceutical Industries Ltd., Hubei Jingxuan Food Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Maharashtra, India
Patent: 14
Hubei Sheng, China
Patent: 9
Shanghai Shi, China
Patent: 8
Shaanxi Sheng, China
Patent: 7
Jiangxi Sheng, China
Patent: 7
Hubei Sheng, China
Patent: 6
Illinois, United States
Patent: 6
STARTUP
Kanagawa-ken, Japan
Patent: 6
Hubei Sheng, China
Patent: 5
Liaoning Sheng, China
Patent: 5
Research Institutions
Order by:
Innovation Intensity
With the analysis among 2,129 patents, we discovered top 235 universities and scientific research institutions by total patent application. China Pharmaceutical University, Chinese Academy of Medical Scciences & Peking Union Medical College, Shanghai Institute of Materia Medica Chinese Academy of Sciences are dominant in this area. They take 9.77% of the total patent filing.
Jiangsu Sheng, China
Patent: 47
Shanghai Shi, China
Patent: 25
Virginia, United States
Patent: 22
South Korea
Patent: 17
Delhi, India
Patent: 15
Beijing Shi, China
Patent: 13
New York, United States
Patent: 13
Shanghai Shi, China
Patent: 13
Louisiana, United States
Patent: 12
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: